130 related articles for article (PubMed ID: 38070170)
1. PATIENT-RELATED FACTORS AND CLINICAL MANAGEMENT OUTCOMES OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract][Full Text] [Related]
2. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X
Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
[TBL] [Abstract][Full Text] [Related]
3. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
Zhao J; Feng ZX; Wei M; Liu G; Solarte CE; Li B; Wang Y; Zhang C; Gallie BL
Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.
Al-Nawaiseh I; Jammal HM; Khader YS; Jaradat I; Barham R
Ophthalmic Epidemiol; 2014 Dec; 21(6):406-11. PubMed ID: 25317653
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation and survival of retinoblastoma in Indian children.
Chawla B; Hasan F; Azad R; Seth R; Upadhyay AD; Pathy S; Pandey RM
Br J Ophthalmol; 2016 Feb; 100(2):172-8. PubMed ID: 26061162
[TBL] [Abstract][Full Text] [Related]
6. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
7. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma presentation, treatment and outcome in a large referral centre in Tehran: a 10-year retrospective analysis.
Faranoush M; Mehrvar N; Tashvighi M; Fabian ID; Zloto O; Bascaran C; Ghorbani R; Ghasemi F; Naseripour M; Sedaghat A; Alebouyeh M; Mehrvar A
Eye (Lond); 2021 Feb; 35(2):575-583. PubMed ID: 32367000
[TBL] [Abstract][Full Text] [Related]
9. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
[TBL] [Abstract][Full Text] [Related]
10. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
11. Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia.
Handayani K; Indraswari BW; Sitaresmi MN; Mulatsih S; Widjajanto PH; Kors WA; Kaspers GJ; Mostert S
Asian Pac J Cancer Prev; 2021 May; 22(5):1613-1621. PubMed ID: 34048193
[TBL] [Abstract][Full Text] [Related]
12. Extra-ocular retinoblastoma: about 12 cases followed at the Mohamed VI university hospital of Marrakech.
Leila S; Ibtissam H; Hafsa E; Abdeljalil M
Pan Afr Med J; 2016; 25():131. PubMed ID: 28292093
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma--a clinico-pathological study in Ilorin, Nigeria.
Owoeye JF; Afolayan EA; Ademola-Popoola DS
Afr J Health Sci; 2006; 13(1-2):117-23. PubMed ID: 17348751
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases.
Lee JA; Choi SY; Kang HJ; Lee JW; Kim H; Kim JH; Sung KW; Shin HY; Ahn HS; Park KD
Br J Ophthalmol; 2014 Oct; 98(10):1355-9. PubMed ID: 24795337
[TBL] [Abstract][Full Text] [Related]
15. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
Ye H; Du Y; Chen R; Luo X; Mao Y; Ai S; Ma W; Ding Y; Li Q; Yang H
Curr Eye Res; 2016 Nov; 41(11):1507-1512. PubMed ID: 27158739
[TBL] [Abstract][Full Text] [Related]
16. Vitrectomy in eyes with unsuspected retinoblastoma.
Shields CL; Honavar S; Shields JA; Demirci H; Meadows AT
Ophthalmology; 2000 Dec; 107(12):2250-5. PubMed ID: 11097606
[TBL] [Abstract][Full Text] [Related]
17. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
[TBL] [Abstract][Full Text] [Related]
18. [Retinoblastoma in Kenya: survival and prognostic factors].
Gichigo EN; Kariuki-Wanyoike MM; Kimani K; Nentwich MM
Ophthalmologe; 2015 Mar; 112(3):255-60. PubMed ID: 25378130
[TBL] [Abstract][Full Text] [Related]
19. Role of PET/CT in staging and evaluation of treatment response after 3 cycles of chemotherapy in locally advanced retinoblastoma: a prospective study.
Radhakrishnan V; Kumar R; Malhotra A; Bakhshi S
J Nucl Med; 2012 Feb; 53(2):191-8. PubMed ID: 22251556
[TBL] [Abstract][Full Text] [Related]
20. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
